HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

236.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 325.00
  • 52 Week Low: 189.00
  • Currency: UK Pounds
  • Shares Issued: 872.11m
  • Volume: 10,132
  • Market Cap: £2,058.18m
  • RiskGrade: 226

Latest ShareCast News

Hutchmed enrols last patient in phase 3 lung cancer trial

By Josh White

Date: Wednesday 20 Aug 2025

(Sharecast News) - Hutchmed China said in an update on Wednesday that it has completed patient enrollment in its phase three 'Sanovo' trial in China testing a combination of 'Orpathys', or savolitinib, and 'Tagrisso', or osimertinib, as a first-line therapy for certain non-small cell lung cancer patients.

HCM Regulatory News

2025 Interim Results 07-Aug-2025 12:00 RNS
HUTCHMED to Announce 2025 Half-Year Results 03-Jul-2025 09:30 RNS
Update on Joint Corporate Brokers in London 02-Jul-2025 10:00 RNS
Blocklisting Six Monthly Return 30-Jun-2025 09:30 RNS
Total Voting Rights 30-Jun-2025 09:30 RNS

HCM News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 236.00p
Change Today -1.00p
% Change -0.42 %
52 Week High 325.00
52 Week Low 189.00
Volume 10,132
Shares Issued 872.11m
Market Cap £2,058.18m
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.68% below the market average43.68% below the market average43.68% below the market average43.68% below the market average43.68% below the market average
31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average
Price Trend
21.97% below the market average21.97% below the market average21.97% below the market average21.97% below the market average21.97% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Income Not Available
Growth
44.06% below the market average44.06% below the market average44.06% below the market average44.06% below the market average44.06% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average

HCM Dividends

No dividends found

Trades for 22-Aug-2025

Time Volume / Share Price
13:50 10,000 @ 235.00p
08:31 103 @ 242.50p
08:04 1 @ 244.00p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page